This is one of the largest IPOs in India's pharmaceutical sector. The firm has set a price band of Rs 1,490-1,500 per share (face value of Re 1). At least 10 ...
Read more: ED asks Gland Pharma to transfer 6 million shares held by Ramalinga Raju to escrow account